Characterization and Identification of Subpopulations of Mononuclear Preosteoclasts Induced by TNF-α in Combination with TGF-β in Rats

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Matsubara, Rei ^a,b   Kukita, Toshio ^b   Ichigi, Yuka ^a   Takigawa, Ippei ^a   Qu, Peng Fei ^b   Funakubo, Noboru ^a,b   Miyamoto, Hiroshi ^a   Nonaka, Kazuaki ^b   Kukita, Akiko ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; COLONY STIMULATING FACTOR 1; EMR 1 ANTIGEN; HYDROXYUREA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE CELL; BONE MARROW CULTURE; BONE TISSUE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUSION; CELL ISOLATION; CELL SUBPOPULATION; CHEMOTAXIS; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FEMALE; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PREOSTEOCLAST; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; STEM CELL; STROMA CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA PRIMERS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HYDROXYUREA; IMMUNOHISTOCHEMISTRY; MACROPHAGE COLONY-STIMULATING FACTOR; MONOCYTE-MACROPHAGE PRECURSOR CELLS; OSTEOCLASTS; RANK LIGAND; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84868117017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047930     Document Type: Article

References (43)

1. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, et al. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357.
2. Roodman GD, (2006) Regulation of osteoclast differentiation. Ann N Y Acad Sci 1068: 100-109.
3. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
4. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95: 3597-3602.
5. Takayanagi H, (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292-304.
6. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, et al. (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200: 941-946.
7. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, et al. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202: 345-351.
8. Oursler MJ, (2010) Recent advances in understanding the mechanisms of osteoclast precursor fusion. J Cell Biochem 110: 1058-1062.
9. Ishizuka H, Garcia-Palacios V, Lu G, Subler MA, Zhang H, et al. (2011) ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J Bone Miner Res 26: 169-181.
10. Hoshino A, Iimura T, Ueha S, Hanada S, Maruoka Y, et al. (2010) Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts. J Biol Chem 285: 28826-28837.
11. Vallet S, Raje N, Ishitsuka K, Hideshima T, Podar K, et al. (2007) MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. Blood 110: 3744-3752.
12. Watanabe T, Kukita T, Kukita A, Wada N, Toh K, et al. (2004) Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 180: 193-201.
13. Yu X, Huang Y, Collin-Osdoby P, Osdoby P, (2004) CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19: 2065-2077.
14. Li X, Qin L, Bergenstock M, Bevelock LM, Novack DV, et al. (2007) Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem 282: 33098-33106.
15. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, et al. (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190: 1741-1754.
16. Kukita T, Kukita A, Nagata K, Maeda H, Kurisu K, et al. (1994) Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor. J Immunol 153: 5265-5273.
17. Kukita T, Kukita A, Xu L, Maeda H, Iijima T, (1998) Successful detection of active osteoclasts in situ by systemic administration of an osteoclast-specific monoclonal antibody. Calcif Tissue Int 63: 148-153.
18. Kukita T, Kukita A, Watanabe T, Iijima T, (2001) Osteoclast differentiation antigen, distinct from receptor activator of nuclear factor kappa B, is involved in osteoclastogenesis under calcitonin-regulated conditions. J Endocrinol 170: 175-183.
19. Komine M, Kukita A, Kukita T, Ogata Y, Hotokebuchi T, et al. (2001) Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone 28: 474-483.
20. Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, et al. (1999) A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2. J Immunol 162: 2754-2760.
21. Harada H, Kukita T, Kukita A, Iwamoto Y, Iijima T, (1998) Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors. Endocrinology 139: 3967-3975.
22. Sakai H, Jingushi S, Shuto T, Urabe K, Ikenoue T, et al. (2002) Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells. Ann Rheum Dis 61: 103-109.
23. Kukita T, Kukita A, Xu L, Watanabe T, Iijima T, (2001) Kat1-antigen-a reliable immunological marker for identifying osteoclast precursors of rats: detection of subpopulations among precursors and initiation of osteoclastogenesis. Histochem Cell Biol 115: 215-222.
24. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, et al. (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 1481-1488.
25. Kim N, Kadono Y, Takami M, Lee J, Lee SH, et al. (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202: 589-595.
26. Kukita A, Kukita T, Shin JH, Kohashi O, (1993) Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells. Biochem Biophys Res Commun 196: 1383-1389.
27. Kukita A, Kukita T, Hata K, Kurisu K, Kohashi O, (1993) Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells. Bone Miner 23: 113-127.
28. Toh K, Kukita T, Wu Z, Kukita A, Sandra F, et al. (2004) Possible involvement of MIP-1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis. Lab Invest 84: 1092-1102.
29. Takahashi N, Udagawa N, Tanaka S, Murakami H, Owan I, et al. (1994) Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol 163: 212-221.
30. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
31. Soehnlein O, Lindbom L, (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-439.
32. Benoit M, Desnues B, Mege JL, (2008) Macrophage polarization in bacterial infections. J Immunol 181: 3733-3739.
33. Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N, (2006) Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther 8: R152.
34. Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, et al. (2006) Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 281: 11846-11855.
35. Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, et al. (2004) Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum 50: 265-276.
36. Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, et al. (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458: 524-528.
37. Karst M, Gorny G, Galvin RJ, Oursler MJ, (2004) Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol 200: 99-106.
38. Houde N, Chamoux E, Bisson M, Roux S, (2009) Transforming growth factor-beta1 (TGF-beta1) induces human osteoclast apoptosis by up-regulating Bim. J Biol Chem 284: 23397-23404.
39. Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, et al. (2003) Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem 278: 44975-44987.
40. Fox SW, Evans KE, Lovibond AC, (2008) Transforming growth factor-beta enables NFATc1 expression during osteoclastogenesis. Biochem Biophys Res Commun 366: 123-128.
41. Ishida N, Hayashi K, Hattori A, Yogo K, Kimura T, et al. (2006) CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J Bone Miner Res 21: 48-57.
42. Dairaghi DJ, Oyajobi BO, Gupta A, McCluskey B, Miao S, et al. (2012) CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood 120: 1449-1457.
43. Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, et al. (2009) Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med 15: 417-424.